213,285 research outputs found
Kaplan-Meier survival curves of all-cause mortality after CPI (including groups B, C, and D).
Kaplan-Meier survival curves of all-cause mortality after CPI (including groups B, C, and D).</p
Kaplan-Meier survival analysis by baseline MLHFQ score tercile.
(A) Kaplan-Meier survival analysis of the first quartile (score 0–28). (B) Kaplan-Meier survival analysis of the second quartile (score 28–39). (C) Kaplan-Meier survival analysis of the third quartile (score 39–48). (D) Kaplan-Meier survival analysis of the forth quartile (score >48).</p
Kaplan-Meier survival curve.
Percent survival is shown in this Kaplan-Meier survival curve.</p
Kaplan-Meier survival curves in the four predefined subgroups.
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, stroke and acute non-fatal myocardial infarction). Log-Rank test (Mantel-Cox); p<0.001. B: Kaplan Meier survival curve for all-cause mortality. Log-Rank test (Mantel-Cox); p<0.001. C: Kaplan Meier survival curve for BARC 3–5 bleeding events. Log-Rank test (Mantel-Cox); p = 0.846.</p
Kaplan-Meier curve of survival by presence of NSVT.
Panel A shows Kaplan-Meier survival curve in patients with or without NSVT. Panel B shows Kaplan-Meier curve of CV hospitalization-free survival in patients with or without NSVT. Panel C shows Kaplan-Meier curve of stroke-free survival in patients with or without NSVT. Panel D shows Kaplan-Meier curve of occurrence of new-onset HF free survival in patients with or without NSVT. CV indicates cardiovascular; CVA, cerebral vascular accident; HF, heart failure; NSVT, non-sustained ventricular tachycardia.</p
Kaplan-Meier curves among different metastasis status.
The Kaplan-Meier survival curves show the differences on survival probabilities among metastasis, non-metastasis and unknown metastasis status at bone (A), brain (B) and lung (C).</p
Kaplan-Meier curves for different metastatic sites.
The Kaplan-Meier survival curves show the differences on survival probabilities among < 50 years, 50–59 years and ≥ 60 years patients with bone metastasis (A), brain metastasis (B), lung metastasis (C) and unknown metastasis (D).</p
Kaplan-Meier curves based on different factors.
The Kaplan-Meier survival curves show the differences on survival probabilities within high and low risk (A), among three age groups (B), among five histologic types (C) and whether received primary site surgery or not (D).</p
Kaplan-Meier analysis according to the original Oxford MESC vs. modified M´E´S´C´ cutoffs in the validation cohort.
Kaplan-Meier analysis according to the original Oxford MESC vs. modified M´E´S´C´ cutoffs in the validation cohort.</p
- …
